High STMN1 expression leads to shorter post-progression and overall survival in breast cancer patients29, consistent with our finding that STMN1 is up-regulated among tumor samples in the ‘early recurrence’ group (labelled ‘red’ in Fig. 3c). Here, STMN1 is linked to breast carcinoma.